A retrospective study assessing the safety and efficacy of Liraglutide alone and sulfonylurea combination therapy in Japanese type II diabetes patients and its association with beta cell function.

Trial Profile

A retrospective study assessing the safety and efficacy of Liraglutide alone and sulfonylurea combination therapy in Japanese type II diabetes patients and its association with beta cell function.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Oct 2016

At a glance

  • Drugs Liraglutide (Primary) ; Sulfonylureas
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top